In 2026 Medicare families face two paths: the Guiding an Improved Dementia Experience (GUIDE) Model for support and a registry path for Alzheimer's drugs. GUIDE navigation and respite carry no cost-sharing, while infused drugs fall under Part B deductibles and coinsurance. According to CMS, GUIDE launched July 1, 2024, as an eight-year voluntary test the CMS launch summary. CMS reports 390 organizations building Dementia Care Programs to serve hundreds of thousands of beneficiaries.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official notice from CMS — Use this primary source to verify the official announcement.
- Read the official guidance from CMS — Use this primary source to verify the official guidance.
Table of Contents
- What GUIDE Provides Day to Day
- Who Can Enroll in GUIDE?
- What Will Families Pay?
- Why Some Medicare Members Cannot Join
- How Is Alzheimer's Drug Coverage Different?
What GUIDE Provides Day to Day
CMS says GUIDE pays a new Medicare payment for coordination, caregiver education and respite. The aim is to help people with dementia stay in homes and communities. Respite means short breaks for caregivers.
CMS lists a navigator, personal care plan and ongoing monitoring as core parts the GUIDE model overview. A navigator is a main contact who guides care. The same overview includes 24/7 support-line access, caregiver training and links to community resources.
Who Can Enroll in GUIDE?
Alzheimer's Association explains that eligible people have a clinician-confirmed dementia diagnosis. They have Original Medicare Parts A and B as primary payer, live in the community and align to a participating GUIDE provider.
Dual-eligible means enrolled in both Medicare and Medicaid. Alzheimer's Association notes these beneficiaries may qualify, so families should confirm alignment with a local GUIDE provider.
- clinician-confirmed dementia diagnosis
- Original Medicare Parts A and B as primary payer
- live in the community
- aligned to a participating GUIDE provider
What Will Families Pay?
CMS states beneficiaries pay no cost-sharing for GUIDE services the GUIDE payment FAQs. Cost-sharing means out-of-pocket charges.
Participating providers may not charge extra cost-sharing for them. CMS caps respite at $2,500 per patient per year. CMS adjusts the cap each year for inflation.
Why Some Medicare Members Cannot Join
Isaac Health summarizes CMS rules that block alignment during certain coverage or stays. People in Medicare Advantage, including Special Needs Plans, generally cannot join GUIDE while enrolled.
Under those CMS rules, the same limits apply to PACE, the hospice benefit and long-term nursing-home stays. Families should check current coverage or setting before seeking GUIDE alignment.
How Is Alzheimer's Drug Coverage Different?
Alzheimer's Association reports Medicare covers lecanemab and donanemab only with registry enrollment the Association's Medicare coverage guide. The prescribing clinician must enroll the patient in a CMS-approved registry such as ALZ-NET. A registry tracks treatment and outcomes, and this drug path is separate from GUIDE.
Hebrew SeniorLife notes infused drugs fall under Part B with deductibles and roughly 20% coinsurance unless supplemental coverage applies. Coinsurance means your share of the bill. Families should confirm GUIDE provider availability and drug out-of-pocket costs separately.
You Might Also Like
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: Questions Family Caregivers Can Ask About the Research
- The Long-Term Care Data Cooperative and Dementia Research in 2026: Questions Family Caregivers Can Ask About the Research
- NHATS and NSOC Dementia Care Data Priorities in 2026: Questions Family Caregivers Can Ask About the Research
